The end of nandrolone
Gespeichert in:
| Veröffentlicht in: | GMHC treatment issues 2007-01, Vol.21 (1), p.1-3 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 3 |
|---|---|
| container_issue | 1 |
| container_start_page | 1 |
| container_title | GMHC treatment issues |
| container_volume | 21 |
| creator | Vergel, Nelson |
| description | |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_68153675</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68153675</sourcerecordid><originalsourceid>FETCH-LOGICAL-p124t-46ea9e6e271f708c6b84f324f050064a39943c4f95a852fb21d5dfbc2c5160083</originalsourceid><addsrcrecordid>eNo1jz1rwzAUADWkNGnaMWvw1M3w9PTpsYR-BAJd0tnI0hNNsCXXiof--xaaTrccB7dgKw7G1NyiXLK7Us4AaK2CW7bkxiAKASu2OX5SRSlUOVbJpTDlPie6ZzfR9YUerlyzj5fn4-6tPry_7ndPh3rkKC-11OQa0oSGRwPW687KKFBGUABaOtE0UngZG-WswtghDyrEzqNXXANYsWaPf91xyl8zlUs7nIqnvneJ8lxabbkS2qhfcXsV526g0I7TaXDTd_s_In4AAZNAcw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68153675</pqid></control><display><type>article</type><title>The end of nandrolone</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Vergel, Nelson</creator><creatorcontrib>Vergel, Nelson</creatorcontrib><identifier>ISSN: 1077-1824</identifier><identifier>PMID: 17722330</identifier><language>eng</language><publisher>United States</publisher><subject>AIDS/HIV ; Anabolic Agents - supply & distribution ; Anabolic Agents - therapeutic use ; Antiretroviral Therapy, Highly Active ; Drug Industry ; HIV Wasting Syndrome - drug therapy ; Humans ; Nandrolone - supply & distribution ; Nandrolone - therapeutic use ; United States ; United States Food and Drug Administration</subject><ispartof>GMHC treatment issues, 2007-01, Vol.21 (1), p.1-3</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17722330$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Vergel, Nelson</creatorcontrib><title>The end of nandrolone</title><title>GMHC treatment issues</title><addtitle>GMHC Treat Issues</addtitle><subject>AIDS/HIV</subject><subject>Anabolic Agents - supply & distribution</subject><subject>Anabolic Agents - therapeutic use</subject><subject>Antiretroviral Therapy, Highly Active</subject><subject>Drug Industry</subject><subject>HIV Wasting Syndrome - drug therapy</subject><subject>Humans</subject><subject>Nandrolone - supply & distribution</subject><subject>Nandrolone - therapeutic use</subject><subject>United States</subject><subject>United States Food and Drug Administration</subject><issn>1077-1824</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1jz1rwzAUADWkNGnaMWvw1M3w9PTpsYR-BAJd0tnI0hNNsCXXiof--xaaTrccB7dgKw7G1NyiXLK7Us4AaK2CW7bkxiAKASu2OX5SRSlUOVbJpTDlPie6ZzfR9YUerlyzj5fn4-6tPry_7ndPh3rkKC-11OQa0oSGRwPW687KKFBGUABaOtE0UngZG-WswtghDyrEzqNXXANYsWaPf91xyl8zlUs7nIqnvneJ8lxabbkS2qhfcXsV526g0I7TaXDTd_s_In4AAZNAcw</recordid><startdate>200701</startdate><enddate>200701</enddate><creator>Vergel, Nelson</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>200701</creationdate><title>The end of nandrolone</title><author>Vergel, Nelson</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p124t-46ea9e6e271f708c6b84f324f050064a39943c4f95a852fb21d5dfbc2c5160083</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>AIDS/HIV</topic><topic>Anabolic Agents - supply & distribution</topic><topic>Anabolic Agents - therapeutic use</topic><topic>Antiretroviral Therapy, Highly Active</topic><topic>Drug Industry</topic><topic>HIV Wasting Syndrome - drug therapy</topic><topic>Humans</topic><topic>Nandrolone - supply & distribution</topic><topic>Nandrolone - therapeutic use</topic><topic>United States</topic><topic>United States Food and Drug Administration</topic><toplevel>online_resources</toplevel><creatorcontrib>Vergel, Nelson</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>GMHC treatment issues</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vergel, Nelson</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The end of nandrolone</atitle><jtitle>GMHC treatment issues</jtitle><addtitle>GMHC Treat Issues</addtitle><date>2007-01</date><risdate>2007</risdate><volume>21</volume><issue>1</issue><spage>1</spage><epage>3</epage><pages>1-3</pages><issn>1077-1824</issn><cop>United States</cop><pmid>17722330</pmid><tpages>3</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1077-1824 |
| ispartof | GMHC treatment issues, 2007-01, Vol.21 (1), p.1-3 |
| issn | 1077-1824 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_68153675 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
| subjects | AIDS/HIV Anabolic Agents - supply & distribution Anabolic Agents - therapeutic use Antiretroviral Therapy, Highly Active Drug Industry HIV Wasting Syndrome - drug therapy Humans Nandrolone - supply & distribution Nandrolone - therapeutic use United States United States Food and Drug Administration |
| title | The end of nandrolone |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T01%3A37%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20end%20of%20nandrolone&rft.jtitle=GMHC%20treatment%20issues&rft.au=Vergel,%20Nelson&rft.date=2007-01&rft.volume=21&rft.issue=1&rft.spage=1&rft.epage=3&rft.pages=1-3&rft.issn=1077-1824&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E68153675%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68153675&rft_id=info:pmid/17722330&rfr_iscdi=true |